Iterum Therapeutics plc Stock
Stocks
ITRMF
IE000TTOOBX0
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0330 USD | -41.07% |
|
-33.87% | -90.15% |
| 04-16 | Eton Pharmaceuticals, Inc. Announces CFO Changes | CI |
| 04-16 | Eton Pharmaceuticals, Inc. Appoints Judith ?Judy? M. Matthews as Executive Vice President, Accounting and Finance | CI |
| Market Cap | 1.74M 1.52M 1.41M 1.3M 2.45M 167M 2.5M 16.8M 6.59M 82.01M 6.55M 6.4M 282M | P/E 2025 * |
-0.05x | P/E 2026 * | -0.14x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74M 1.52M 1.41M 1.3M 2.45M 167M 2.5M 16.8M 6.59M 82.01M 6.55M 6.4M 282M | EV / Sales 2025 * |
2.18x | EV / Sales 2026 * | 0.17x |
| Free-Float |
99.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Iterum Therapeutics plc
| 1 day | -41.07% | ||
| 1 week | -33.87% | ||
| Current month | -33.87% | ||
| 1 month | -5.98% | ||
| 3 months | +52.78% | ||
| 6 months | -89.88% | ||
| Current year | -90.15% |
| 1 week | 0.03 |  | 0.06 |
| 1 month | 0.03 | | 0.06 |
| Current year | 0 | | 0.39 |
| 1 year | 0 | | 1 |
| 3 years | 0 | | 3.02 |
| 5 years | 0 | | 20.25 |
| 10 years | 0 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tom Loughman
CTO | Chief Tech/Sci/R&D Officer | - | 2016-09-30 |
Steven Aronin
CTO | Chief Tech/Sci/R&D Officer | - | 2017-06-30 |
Louise Barrett
LAW | General Counsel | - | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Beth Hecht
BRD | Director/Board Member | 62 | 2021-03-11 |
David Kelly
CHM | Chairman | 65 | 2025-03-09 |
Joe Whalen
BRD | Director/Board Member | - | 2025-03-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-17 | Buy | Founder | 6,000 | 0.0125% | ||
| 25-08-07 | Buy | Founder | 15,000 | 0.0356% | ||
| 25-06-30 | Free | Executive/Senior Manager | 200,000 | 0.5783% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -41.07% | -33.87% | -96.70% | -97.20% | 1.74M | |
| -0.33% | +1.22% | +2.91% | +7.17% | 50.35B | |
| +0.55% | -2.88% | +382.07% | +593.81% | 39.32B | |
| +0.13% | -0.19% | +29.79% | -6.00% | 34.69B | |
| +0.86% | -0.78% | +21.58% | +56.15% | 34.08B | |
| -1.31% | -3.03% | +2.51% | +25.24% | 26.63B | |
| +0.13% | -0.52% | - | - | 16.49B | |
| +1.13% | -1.85% | +67.36% | +120.46% | 15.31B | |
| +0.14% | +3.04% | +14.63% | +17.64% | 13.8B | |
| +1.13% | -0.44% | +12.34% | -31.79% | 12.87B | |
| Average | -3.86% | -4.13% | +48.50% | +76.16% | 24.35B | |
| Weighted average by Cap. | +0.16% | -0.73% | +81.03% | +122.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 800K 699K 646K 597K 1.12M 76.84M 1.14M 7.71M 3.02M 37.63M 3M 2.94M 130M | 10M 8.74M 8.08M 7.46M 14.06M 961M 14.31M 96.34M 37.8M 470M 37.56M 36.73M 1.62B |
| Net income | -31.4M -27.44M -25.37M -23.44M -44.13M -3.02B -44.93M -303M -119M -1.48B -118M -115M -5.09B | -11.2M -9.79M -9.05M -8.36M -15.74M -1.08B -16.03M -108M -42.33M -527M -42.07M -41.14M -1.81B |
| Net Debt | - | - |
Employees
9
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | US$0.0330 | -41.07% | 28,538 |
| 26-07-13 | US$0.0560 | -0.18% | 1,404 |
| 26-07-10 | US$0.0561 | +115.77% | 8,606 |
| 26-07-09 | US$0.0260 | -7.14% | 31,563 |
| 26-07-08 | US$0.0280 | -43.89% | 138,208 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0330
Average target price
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ITRMF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
